Wen‐Cheng Chou

915 total citations
25 papers, 625 citations indexed

About

Wen‐Cheng Chou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wen‐Cheng Chou has authored 25 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Wen‐Cheng Chou's work include DNA Repair Mechanisms (6 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related Molecular Pathways (4 papers). Wen‐Cheng Chou is often cited by papers focused on DNA Repair Mechanisms (6 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related Molecular Pathways (4 papers). Wen‐Cheng Chou collaborates with scholars based in Taiwan, United States and China. Wen‐Cheng Chou's co-authors include Chen‐Yang Shen, Hui‐Chun Wang, Sheau-Yann Shieh, Chia‐Ni Hsiung, Ling‐Yueh Hu, Hou‐Wei Chu, Pei-Ei Wu, Fen-Hwa Wong, Jyh‐Cherng Yu and Huan-Ming Hsu and has published in prestigious journals such as The EMBO Journal, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Wen‐Cheng Chou

25 papers receiving 620 citations

Peers

Wen‐Cheng Chou
Kristian B. Laursen United States
Jin-Ho Kang South Korea
Yajie Yin United States
Wen‐Cheng Chou
Citations per year, relative to Wen‐Cheng Chou Wen‐Cheng Chou (= 1×) peers Noriyo Hayakawa

Countries citing papers authored by Wen‐Cheng Chou

Since Specialization
Citations

This map shows the geographic impact of Wen‐Cheng Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Cheng Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Cheng Chou more than expected).

Fields of papers citing papers by Wen‐Cheng Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Cheng Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Cheng Chou. The network helps show where Wen‐Cheng Chou may publish in the future.

Co-authorship network of co-authors of Wen‐Cheng Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Cheng Chou. A scholar is included among the top collaborators of Wen‐Cheng Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Cheng Chou. Wen‐Cheng Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Te-An, Wen‐Cheng Chou, Cheng‐Chang Chang, et al.. (2025). Regulation of PD-L1 glycosylation and advances in cancer immunotherapy. Cancer Letters. 612. 217498–217498. 6 indexed citations
2.
Chou, Wen‐Cheng, Wei‐Ting Chen, Yao‐Ming Chang, et al.. (2023). Genetic insights into carbohydrate sulfotransferase 8 and its impact on the immunotherapy efficacy of cancer. Cell Reports. 43(1). 113641–113641. 4 indexed citations
4.
Chou, Wen‐Cheng, et al.. (2022). A common variant in 11q23.3 associated with hyperlipidemia is mediated by the binding and regulation of GATA4. npj Genomic Medicine. 7(1). 4–4. 10 indexed citations
5.
Lai, Yun‐Ju, Chi-Hong Chao, Chun‐Che Liao, et al.. (2021). Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail.. PubMed. 11(5). 2278–2290. 24 indexed citations
6.
Chou, Wen‐Cheng, Chia‐Ni Hsiung, Wei‐Ting Chen, et al.. (2020). A functional variant near XCL1 gene improves breast cancer survival via promoting cancer immunity. International Journal of Cancer. 146(8). 2182–2193. 14 indexed citations
7.
Chen, Chung‐Jen, Chia‐Chun Tseng, Jeng‐Hsien Yen, et al.. (2018). ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study. Scientific Reports. 8(1). 3137–3137. 54 indexed citations
8.
Chou, Wen‐Cheng, Weiting Chen, Chia‐Ni Hsiung, et al.. (2017). B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers. Scientific Reports. 7(1). 44089–44089. 25 indexed citations
9.
Lin, Wen‐Yen, et al.. (2017). Realization of a CORDIC-Based Plug-In Accelerometer Module for PSG System in Head Position Monitoring for OSAS Patients. Journal of Healthcare Engineering. 2017. 1–9. 8 indexed citations
10.
Chou, Wen‐Cheng, et al.. (2015). The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity. PLoS ONE. 10(6). e0128472–e0128472. 41 indexed citations
11.
Huang, Ya-Chen, et al.. (2015). FGFR2 regulates Mre11 expression and double-strand break repair via the MEK-ERK-POU1F1 pathway in breast tumorigenesis. Human Molecular Genetics. 24(12). 3506–3517. 20 indexed citations
12.
Chou, Wen‐Cheng, Ling‐Yueh Hu, Chia‐Ni Hsiung, & Chen‐Yang Shen. (2015). Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway. Carcinogenesis. 36(8). 832–840. 32 indexed citations
13.
Kuo, Ching‐Ying, Wen‐Cheng Chou, Chin‐Chung Wu, et al.. (2015). Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms. Oncotarget. 6(28). 25770–25783. 8 indexed citations
14.
Chu, Hou‐Wei, Chun‐Wen Cheng, Wen‐Cheng Chou, et al.. (2013). A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis. Human Molecular Genetics. 23(2). 355–367. 51 indexed citations
15.
Wang, Hui‐Chun, Alan Yueh‐Luen Lee, Wen‐Cheng Chou, et al.. (2012). Inhibition of ATR-Dependent Signaling by Protoapigenone and Its Derivative Sensitizes Cancer Cells to Interstrand Cross-link–Generating Agents In Vitro and In Vivo. Molecular Cancer Therapeutics. 11(7). 1443–1453. 31 indexed citations
16.
Chu, Hou‐Wei, Chun‐Wen Cheng, Wen‐Cheng Chou, et al.. (2012). Abstract 144: MicroRNA-190, regulated by estrogen receptor signaling, suppresses expression of the metastasis-promoting gene PAR-1 and is associated with breast cancer progression. Cancer Research. 72(8_Supplement). 144–144. 2 indexed citations
17.
Chou, Wen‐Cheng, Yi‐Wen Lin, Chin-Yi Cheng, et al.. (2012). 2 Hz Electro-Acupuncture at Yinlingquan (SP9) and Ququan (LR8) Acupoints Induces Changes in Blood Flow in the Liver and Spleen. The American Journal of Chinese Medicine. 40(1). 75–84. 11 indexed citations
18.
Yu, Jyh‐Cherng, Chia‐Ni Hsiung, Huan-Ming Hsu, et al.. (2011). Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development. Breast Cancer Research. 13(1). R13–R13. 29 indexed citations
19.
Chou, Wen‐Cheng, Hui‐Chun Wang, Fen-Hwa Wong, et al.. (2008). Chk2‐dependent phosphorylation of XRCC1 in the DNA damage response promotes base excision repair. The EMBO Journal. 27(23). 3140–3150. 89 indexed citations
20.
Wang, Hui‐Chun, Wen‐Cheng Chou, Sheau-Yann Shieh, & Chen‐Yang Shen. (2006). Ataxia Telangiectasia Mutated and Checkpoint Kinase 2 Regulate BRCA1 to Promote the Fidelity of DNA End-Joining. Cancer Research. 66(3). 1391–1400. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026